Article info
Discussion
Terbutaline: level the playing field for inhaled β2-agonists by introducing a dosing and urine threshold
- Correspondence to Dr Glenn A Jacobson, School of Medicine, Private Bag 26, Hobart, Tasmania 7001, Australia; glenn.jacobson{at}utas.edu.au
Citation
Terbutaline: level the playing field for inhaled β2-agonists by introducing a dosing and urine threshold
Publication history
- Accepted July 1, 2016
- First published July 26, 2016.
Online issue publication
August 25, 2017
Article Versions
- Previous version (26 July 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/